Serotonin transporter inhibits antitumor immunity through regulating the intratumoral serotonin axis

By sjmartinez • May 23, 2025

Li B, Elsten-Brown J, Li M, Zhu E, Li Z, Chen Y, Kang E, Ma F, Chiang J, Li YR, Zhu Y, Huang J, Fung A, Scarborough Q, Cadd R, Zhou JJ, Chin AI, Pellegrini M, Yang L. Serotonin transporter inhibits antitumor immunity through regulating the intratumoral serotonin axis. Cell. 2025 May 20:S0092-8674(25)00502-1. doi: 10.1016/j.cell.2025.04.032. Epub ahead of print. PMID: 40403728.

Tags: antidepressants, cancer immunotherapy, Cardiology/Epi, Dermatology, immune checkpoint, intratumoral serotonin axis, PD-1 blockade, Publications, serotonin, serotonin transporter, SSRIs, T cell antitumor immunity, tumor microenvironment, Veterans Administration

Trimethylamine-N-oxide (TMAO) and risk of incident cardiovascular events in the multi ethnic study of Atherosclerosis

Budoff MJ, de Oliveira Otto MC, Li XS, Lee Y, Wang M, Lai HTM, Lemaitre RN, Pratt A, Tang WHW, Psaty BM, Siscovick DS, Hazen[...]

Exploring depression treatment response by using polygenic risk scoring across diverse populations

Lapinska S, Pimplaskar A, Shi Z, Ding Y, Frydman-Gani C, Hou K, Venkateswaran V, Boulier K, Olde Loohuis LM, Pasaniuc B. Exploring depression treatment response[...]

A molecular tango between chromatin and metabolites orchestrates a feedback switch for alcohol consumption

Schmidt HM, Tarling EJ, Vallim TQA. A molecular tango between chromatin and metabolites orchestrates a feedback switch for alcohol consumption. Proc Natl Acad Sci U[...]